Heartflow, Inc. reported $212M of revenue over the trailing twelve months, +43% on the year before. 9 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $212M (to Q2 2026). Net Income: −$118M, trailing twelve months to Q2 2026. Free Cash Flow: −$59M, trailing twelve months to Q2 2026. Op Margin: −38%, trailing twelve months to Q2 2026.

HTFLHeartflow, Inc.

HealthcareUSD

$48.89

$20.4952 weeks$50.20

HTFL as reported

Heartflow, Inc. reported $212M of revenue over the trailing twelve months, +43% on the year before. 9 reported series are charted on this page, each one as filed.

$212M

Revenue, trailing twelve months · to Q2 2026 · +43% against the twelve months before

Net Income: −$118M
Net Income · +26% year on year · trailing twelve months to Q2 2026
Free Cash Flow: −$59M
Free Cash Flow · −13% year on year · trailing twelve months to Q2 2026
Op Margin: −38%
Op Margin · trailing twelve months to Q2 2026

Every series Ryufin has for HTFL, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$212M	+43%	Q2 2026
Net Income	−$118M	+26%	Q2 2026
EPS	−$0.24	−98%	Q2 2026
Gross Margin	80%	n/a	Q2 2026
Op Margin	−38%	n/a	Q2 2026
Net Margin	−59%	n/a	Q2 2026
ROE	−42%	n/a	Q2 2026
ROA	−33%	n/a	Q2 2026
Free Cash Flow	−$59M	−13%	Q2 2026